| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Articles |
Laboratory of Genetics and Physiology, National Institute of Digestive, Diabetes and Kidney Disease, NIH, Bethesda, Maryland 20892
Abstract
The mammary gland undergoes extensive tissue remodeling and cell death at the end of lactation in a process known as involution. We present evidence that the prolactin-activated transcription factor signal transducer and activator of transcription 5a (Stat5a) has a crucial role in the regulation of cell death during mammary gland involution. In a transforming growth factor-
transgenic mouse model that exhibited delayed mammary gland involution, the absence of Stat5a facilitated involution-associated changes in morphology of the gland and the extent and timing of programmed cell death. These Stat5a-dependent changes also affected epidermal growth factor receptor-initiated mammary gland tumorigenesis. Overexpression of the transforming growth factor transgene in the mammary epithelium reproducibly generated mammary hyperplasia and tumors. In the presence of the activated epidermal growth factor receptor, deletion of Stat5a delayed initial hyperplasia and mammary tumor development by 6 weeks. These observations demonstrate that Stat5a is a survival factor, and its presence is required for the epithelium of the mammary gland to resist regression and involution-mediated apoptosis. We also suggest that Stat5a is one of the antecedent, locally acting molecules that initiate the process of epithelial regression and reorganization during involution.
This article has been cited by other articles:
 |
|
 |
|
  L. Hennighausen and G. W. Robinson Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B Genes & Dev., March 15, 2008; 22(6): 711 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J Brennan, J. A Sharp, E. Khalil, M. R Digby, S. L Mailer, C. M Lefevre, and K. R Nicholas A population of mammary epithelial cells do not require hormones or growth factors to survive J. Endocrinol., March 1, 2008; 196(3): 483 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Sotgia, H. Rui, G. Bonuccelli, I. Mercier, R. G. Pestell, and M. P. Lisanti Caveolin-1, Mammary Stem Cells, and Estrogen-Dependent Breast Cancers. Cancer Res., November 15, 2006; 66(22): 10647 - 10651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. E. Clarkson, M. P. Boland, E. A. Kritikou, J. M. Lee, T. C. Freeman, P. G. Tiffen, and C. J. Watson The Genes Induced by Signal Transducer and Activators of Transcription (STAT)3 and STAT5 in Mammary Epithelial Cells Define the Roles of these STATs in Mammary Development Mol. Endocrinol., March 1, 2006; 20(3): 675 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Blakely, L. Sintasath, C. M. D'Cruz, K. T. Hahn, K. D. Dugan, G. K. Belka, and L. A. Chodosh Developmental stage determines the effects of MYC in the mammary epithelium Development, March 1, 2005; 132(5): 1147 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Nevalainen, J. Xie, J. Torhorst, L. Bubendorf, P. Haas, J. Kononen, G. Sauter, and H. Rui Signal Transducer and Activator of Transcription-5 Activation and Breast Cancer Prognosis J. Clin. Oncol., June 1, 2004; 22(11): 2053 - 2060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Faulds, H. Olsen, L. A. Helguero, J.-A. Gustafsson, and L.-A. Haldosen Estrogen Receptor Functional Activity Changes during Differentiation of Mammary Epithelial Cells Mol. Endocrinol., February 1, 2004; 18(2): 412 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Suchyta, S. Sipkovsky, R. G. Halgren, R. Kruska, M. Elftman, M. Weber-Nielsen, M. J. Vandehaar, L. Xiao, R. J. Tempelman, and P. M. Coussens Bovine mammary gene expression profiling using a cDNA microarray enhanced for mammary-specific transcripts Physiol Genomics, December 16, 2003; 16(1): 8 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Kloth, K. K. Laughlin, J. S. Biscardi, J. L. Boerner, S. J. Parsons, and C. M. Silva STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor J. Biol. Chem., January 10, 2003; 278(3): 1671 - 1679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Iavnilovitch, B. Groner, and I. Barash Overexpression and Forced Activation of Stat5 in Mammary Gland of Transgenic Mice Promotes Cellular Proliferation, Enhances Differentiation, and Delays Postlactational Apoptosis Mol. Cancer Res., November 1, 2002; 1(1): 32 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Shan, M. He, M. Yu, C. Qiu, N. H. Lee, E. T. Liu, and E. G. Snyderwine cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene Carcinogenesis, October 1, 2002; 23(10): 1561 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Humphreys, B. Bierie, L. Zhao, R. Raz, D. Levy, and L. Hennighausen Deletion of Stat3 Blocks Mammary Gland Involution and Extends Functional Competence of the Secretory Epithelium in the Absence of Lactogenic Stimuli Endocrinology, September 1, 2002; 143(9): 3641 - 3650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Wiseman and Z. Werb Stromal Effects on Mammary Gland Development and Breast Cancer Science, May 10, 2002; 296(5570): 1046 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Nevalainen, J. Xie, L. Bubendorf, K.-U. Wagner, and H. Rui Basal Activation of Transcription Factor Signal Transducer and Activator of Transcription (Stat5) in Nonpregnant Mouse and Human Breast Epithelium Mol. Endocrinol., May 1, 2002; 16(5): 1108 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Capuco, M. Li, E. Long, S. Ren, K. S. Hruska, K. Schorr, and P. A. Furth Concurrent Pregnancy Retards Mammary Involution: Effects on Apoptosis and Proliferation of the Mammary Epithelium after Forced Weaning of Mice Biol Reprod, May 1, 2002; 66(5): 1471 - 1476. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Shan, S. A. Rouhani, H. A. J. Schut, and E. G. Snyderwine 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Modulates Lactogenic Hormone-mediated Differentiation and Gene Expression in HC11 Mouse Mammary Epithelial Cells Cell Growth Differ., December 1, 2001; 12(12): 649 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Miyoshi, J. M. Shillingford, G. H. Smith, S. L. Grimm, K.-U. Wagner, T. Oka, J. M. Rosen, G. W. Robinson, and L. Hennighausen Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium J. Cell Biol., November 12, 2001; 155(4): 531 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Faulds, K. Pettersson, J.-A. Gustafsson, and L.-A. Haldosen Cross-Talk Between ERs and Signal Transducer and Activator of Transcription 5 Is E2 Dependent and Involves Two Functionally Separate Mechanisms Mol. Endocrinol., November 1, 2001; 15(11): 1929 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Kazansky and J. M. Rosen Signal Transducers and Activators of Transcription 5B Potentiates v-Src-mediated Transformation of NIH-3T3 Cells Cell Growth Differ., January 1, 2001; 12(1): 1 - 7. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
